“The rating reflects our view of Covenant Health’s continued improved operations in fiscal 2016,” said S&P analyst Brian Williamson.
S&P also affirmed the “A” long-term rating and underlying rating on Covenant Health’s series 2006A-1, 2011C and 2012A bonds.
The outlook is stable, reflecting S&P’s belief that Covenant Health’s operations will not be worse than those of fiscal year 2015.
More articles on healthcare finance:
How to build payer-provider collaboration for a more efficient RCM
Olathe Health, Midland tap Cerner for RCM, Verify selects Conifer & More — 12 RCM keynotes
Ronald Blue Co. lowers stake in LifePoint
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
